South Korea approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years
South Korea approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthSouth Korea approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years
Sign in or subscribeBrowse free archive reportsSouth Korea approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.